Revel Health Review
Revel Health is no longer available as we reviewed it, so this page is kept for reference.
Revel Health: Website no longer loads and is not taking patients. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →Revel Health is a telehealth platform combining GLP-1 weight loss with longevity care (semaglutide and tirzepatide plus NAD+, sermorelin and peptide therapy), prescribed by board-certified physicians and compounded in USP 795/800-compliant facilities. You complete an online intake, a physician reviews it within the hour, and medication ships to you. It's LegitScript certified and serves 45 states (not AK, AR, NC, NJ or MS). Published pricing isn't shown upfront.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Revel Health
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Revel Health at a glance
- Type
- GLP-1 telehealth provider
- What's included
- Consult · Shipping · Medication
- Availability
- 45 states
- FDA status
- No FDA warning letter on record
How we scored Revel Health
Each dimension is scored algorithmically from Revel Health’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.2/10Revel Health no longer sells GLP-1 treatment, so no current price applies.
Effectiveness25%
8.0/10Revel Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.3/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.2/10Revel Health is available in 45 states: all but Alaska, Arkansas, Mississippi, New Jersey, North Carolina.
Support10%
5.8/10Revel Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Revel Health review
Last checked August 2026- Confirmed availability in 45 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- State pharmacy licensing & LegitScript status
- LegitScript Certified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Revel Health
We walked Revel Health’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Choose your program and complete checkout.
- 2Complete a secure online intake covering health history.
- 3Provider review and consultation by a licensed provider.
- 4Approval and delivery, shipment in 3-5 business days.
- Prices are shown on product cards before clicking 'Get started' (semaglutide from $199/mo, tirzepatide from $249/mo).
- 100% refund if a physician determines a program is not right for you.
- No support contact listed on the page.
GLP-1 medications Revel Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Revel Health offers
Beyond GLP-1s, Revel Health also offers these peptides. Tap any for our evidence-based guide.
What we like
- LegitScript certified with board-certified physicians and USP 795/800 compounding
- Combines GLP-1 weight loss with NAD+, sermorelin and longevity care
- Fast intake: a physician reviews within the hour
- Available in 45 states with a clear list of where it operates
Watch-outs
- Doesn't show upfront pricing; you learn cost during checkout
- Not available in AK, AR, NC, NJ or MS
- Compounded medications only, with no brand-name options noted
- Longevity add-ons add cost beyond the core GLP-1 program
Is Revel Health still an option?
Revel Health no longer offers a GLP-1 weight-loss program, so there is nothing to sign up for today. We cannot quote a current price, because none exists. We keep this page online so past users can see what it offered and find a program that still operates.
If you were a Revel Health patient, talk with your prescriber before your remaining supply runs out. That keeps treatment going without a gap or an unsafe restart dose. Then compare current providers on price, medication and state coverage. Our page of Revel Health alternatives lists programs that still operate, and the ranked list of semaglutide providers shows where each one stands. If you need a new prescription, our guide on how to get a GLP-1 prescription walks through the steps.
The Bottom Line
Revel Health is no longer available as we reviewed it, so this page is kept for reference.
Revel Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Revel Health review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.